Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis
Clinical trial NCT05866809 · COMPLETED
Trial details
- NCT number
- NCT05866809
- Sponsor
- CuromeBiosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2023-06-23
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.